Total Funding
18
Total FundingSeed raised
Growth Score
pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
AI company focused on disease diagnosis to improve patient outcomes and reduce healthcare costs
Dr. Richard Mammone: Founder
Keith Gray: VCEO
About the Company
ClearView Diagnostics has developed deep-learning/AI software to target and identify breast cancer – providing radiologists a quick and inexpensive way to indicate whether or not a woman has breast cancer. Leveraging funding from seed capital, ClearView has been awarded two rounds of National Institutes of Health (NIH) grants to undergo
extensive studies in Mexico. In January 2017 the FDA issued a 510(k) for the ClearView cCAD product and the team is moving forward to test in the United States with University Radiology Group, one of the largest, most subspecialized, Board Certified radiology practices in the U.S.
Women Founded
